Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted Psychotherapy for Methamphetamine Use Disorder
NCT06538285Phase 2Completed
- Start
- Mar 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine in methamphetamine use disorder (MUD). Primary endpoints: Trial Recruitment at 28 days, Trial Completion at 35 days and 1 more. Started Mar 2025; status: completed.
02
Drugs
ketamine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT06538285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06538285.